
Grifols completes development of molecular test to detect SARS-CoV-2 virus
Catalan Economy
06 May 2020
“Having sufficient molecular test capacity is critical to helping control this pandemic, and having a high-sensitivity test to handle a possible ‘pooling’ strategy is, without a doubt, a differentiating factor, which could make it feasible,” said Victor Grifols Deu, Grifols co-CEO in the company’s press release.
Grifols began developing its test to detect SARS-CoV-2 the first week of February, through its teams in San Diego, Bilbao and Barcelona.
Source: Grifols
Related News and Success stories.
-
07 May 2025
Barcelona, named Europe’s 4th Best City in 2025
-
24 Apr 2025
5 Reasons to Choose Barcelona-Catalonia for Your Life Sciences Expansion
-
14 Apr 2025
Catalonia takes over the presidency of the Four Motors for Europe
-
09 Apr 2025
Catalonia will invest €400 million in InnoFAB, a center for advanced semiconductor development